en | fr
  The Limits to Governance - The Challenge of Policy-Making for the New Life Sciences | 30.06.2009
  • Does the state still frame debates about new technology? Can policy-makers ensure the benefits of health developments through genomics while still satisfying the expectations of society and the economic imperatives?
    In this critique of t...

  •   La protection des données médicales - Les défis du XXIe siècle | 11.06.2008
     

    Le traitement des données médicales face aux défis technologiques du XXIe siècle

    La réglementation des données médicales est aujourd’hui un thème majeur du droit médical et du droit de...

      Comparative Biobank Governance: Challenges, Strategies, Transformations | 30.04.2008

    About the Book

    In recent years, a number of large population-based biobanks – genetic databases that combine genetic information derived from blood samples with personal data about environment, medical history, lifest...

      Risks in the Making: Travels in Life Insurance and Genetics | 13.06.2007

    In recent decades, insurance companies, scientists, and public officials have debated the potential use of genetic testing in insurance decisions. With Risks in the Making, Ine van Hoyweghen alters the terms of the debate, moving it from abstract,...

      The Politics of Biotechnology in North America and Europe: Policy Networks, Institutions and Internationalization | 01.11.2006

    "Two of the most prominent applications of biotechnology assisted reproductive technology and genetic modification of plants have stirred strong feelings and led to widely varying approaches among North American and European co...